Micro-RNA and COVID-19 study
Part of Infections, Lungs & breathing clinical trials.
This trial studies tiny molecules in your body called micro-RNAs (miRNAs) that may help understand how COVID-19 affects people. Participants donate blood and swab samples to see if these molecules can predict how sick someone might get.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have tested positive for COVID-19 using a nasal swab test.
- You are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether different COVID-19 tests (a blood test and swab-based tests) can detect or confirm infection. If you join, you’ll follow the study steps so researchers can compare results and improve testing.
This study looks at how the body's immune system reacted to COVID-19 in people who had either severe or mild cases. The goal is to learn more about a specific part of the immune response (called IFN-I) to better understand the disease.
This trial studies people with mild to moderate COVID-19 symptoms to better understand and help “post-COVID” condition (ongoing effects after infection). You may be eligible if you’re an adult with a recent confirmed COVID-19 test and you agreed to take part.
This study looks at how your immune system responds to COVID-19 or the flu. It may help researchers understand these infections better, whether you are currently sick or healthy.
This trial collects and studies COVID-19 test results and other patient information to better predict treatment response and outcomes. Your sample(s) help researchers understand who may improve, worsen, or need different care.
This study looks at tiny molecules called microRNAs in the blood of people with either small testicular tumors (less than 2 cm) or leftover lymph node masses after chemotherapy for testicular cancer. The goal is to see if these microRNAs can help guide treatment decisions.
Hear when a new COVID-19 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.